ST3GAL6
Type 2 lactosamine alpha-2,3-sialyltransferase
Also known as: SIA10_HUMAN, SIAT10, ST3GALVI
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y274
- Gene
- ST3GAL6
- Ensembl
- ENSG00000064225
- Chromosome
- 3
- Canonical length
- 331 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
The protein encoded by this gene is a member of the sialyltransferase family. Members of this family are enzymes that transfer sialic acid from the activated cytidine 5'-monophospho-N-acetylneuraminic acid to terminal positions on sialylated glycolipids (gangliosides) or to the N- or O-linked sugar chains of glycoproteins. This protein has high specificity for neolactotetraosylceramide and neolactohexaosylceramide as glycolipid substrates and may contribute to the formation of selectin ligands and sialyl Lewis X, a carbohydrate important for cell-to-cell recognition and a blood group antigen. [provided by RefSeq, Apr 2016]
Canonical amino-acid sequenceUniProt
331 residues, UniProt reviewed canonical sequence.
>Q9Y274|ST3GAL6
1 MRGYLVAIFL SAVFLYYVLH CILWGTNVYW VAPVEMKRRN KIQPCLSKPA FASLLRFHQF
61 HPFLCAADFR KIASLYGSDK FDLPYGMRTS AEYFRLALSK LQSCDLFDEF DNIPCKKCVV
121 VGNGGVLKNK TLGEKIDSYD VIIRMNNGPV LGHEEEVGRR TTFRLFYPES VFSDPIHNDP
181 NTTVILTAFK PHDLRWLLEL LMGDKINTNG FWKKPALNLI YKPYQIRILD PFIIRTAAYE
241 LLHFPKVFPK NQKPKHPTTG IIAITLAFYI CHEVHLAGFK YNFSDLKSPL HYYGNATMSL
301 MNKNAYHNVT AEQLFLKDII EKNLVINLTQ DLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ST3GAL6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- liver: 39 nTPM
- heart muscle: 21 nTPM
- salivary gland: 12 nTPM
- adipose tissue: 11 nTPM
- kidney: 10 nTPM
- skin: 8.6 nTPM
Single-cell type
- podocytes: 1,444 nCPM
- bergmann glia: 722 nCPM
- cardiomyocytes: 556 nCPM
- melanocytes: 428 nCPM
- salivary acinar cells: 391 nCPM
- microglia: 280 nCPM
Immune cell
- neutrophil: 51 nTPM
- eosinophil: 41 nTPM
- myeloid DC: 20 nTPM
- basophil: 19 nTPM
- classical monocyte: 15 nTPM
- intermediate monocyte: 8.2 nTPM
Brain region
- medulla oblongata: 25 nTPM
- spinal cord: 21 nTPM
- cerebellum: 19 nTPM
- white matter: 18 nTPM
- pons: 17 nTPM
- cerebral cortex: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.2
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.91
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to interleukin-6
- glycolipid biosynthetic process
- glycoprotein biosynthetic process
- keratan sulfate proteoglycan biosynthetic process
- oligosaccharide biosynthetic process
Molecular functions
- beta-galactoside (CMP) alpha-2,3-sialyltransferase activity
- N-acetyllactosaminide alpha-2,3-sialyltransferase activity
- sialyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ST3GAL6 as an antibody target. Whether an autoantibody or antibody against ST3GAL6 could matter depends on whether native ST3GAL6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ST3GAL6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ST3GAL6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...